This is an article about how great BG-12 is - and it may very well be so. What's so funny is the following paragraph which pretty much sums up what's wrong with current treatments. ... 2012-02-29

According to insights from surveyed U.S. neurologists and MCO pharmacy directors, decreased risk of sustained disability progression is also one of the greatest unmet needs in relapsing-remitting multiple sclerosis.

What? Reducing the risk of disability progressoin "one of the greatest unmet needs in RRMS?". This reporter nailed it.